Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.
Carlos SolanoEstela GiménezJosé Luis PiñanaEliseo AlbertVíctor VinuesaJuan Carlos Hernández-BoludaPaula AmatDavide NavarroPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2017)
Therefore, the data suggest that withholding preemptive antiviral therapy until the plasma CMV DNA load reaches 1500 IU/mL has no apparent detrimental effect on patient survival.
Keyphrases
- stem cells
- free survival
- stem cell transplantation
- bone marrow
- circulating tumor
- case report
- cardiovascular events
- electronic health record
- cell free
- single molecule
- epstein barr virus
- big data
- diffusion weighted imaging
- risk factors
- cell therapy
- cardiovascular disease
- magnetic resonance imaging
- computed tomography
- mesenchymal stem cells
- low dose
- high dose
- machine learning